ALTURiX Supports US Cambridge Health Alliance Harvard Study
ALTURiX is pleased to announce its support for the NACinCOVID Study which is being coordinated by the Cambridge Health Alliance (CHA) based in Cambridge, Massachusetts. Read More
All Products Back In Stock At Movianto
Issued: 12th October 2020, Milton Keynes. Following a period of unpredictable growth in product demand, ALTURiX is aware that recently local… Read More
ALTURiX Acquires Slow-K® UK Rights
ALTURiX is pleased to announce that it has acquired the UK rights to Slow-K® from Alliance Pharmaceuticals. Alliance withdrew Slow-K® from the market in late… Read More
May COVID-19 Update
The world continues to face the challenges of the global threat from COVID-19, and we at ALTURiX continue to do everything we can to play… Read More
COVID-19 Update
The ALTURiX mission is to provide medicines value, and to do so reliably to help the NHS improve patient outcomes. Never has this been more… Read More
ALTURiX Launches
Announced today, ALTURiX – a new British company – has conditionally acquired the rights to a portfolio of well-known medicines which are prescribed widely by the… Read More
Atlantic Supports UK Respiratory Show Launch
Atlantic Pharma demonstrated its commitment to the respiratory field with its support as a Launch Partner for the inaugural Respiratory Show in Birmingham recently. Lung… Read More
UK Wholesaler Agreements
HK Pharma and Atlantic Pharma are pleased to announce new three-year distribution agreements for their products with Alliance Healthcare UK, and PHOENIX. From 1st June… Read More
Modern Manufacturing Practices
The Falsified Medicines Directive is legislation passed by the European Union Parliament, which aims to increase the security of the manufacturing and delivery of prescription… Read More
Arab Health: Increasing Our Distribution Network
For 44 years Arab Health has brought delegates the latest innovations in healthcare. From state-of-the-art imaging equipment to the most cost-effective medicines and disposables; developments… Read More
Distribution Agreement
HK Pharma, Atlantic Pharma and Movianto UK are pleased to announce a new three-year distribution agreement for all products. HK Pharma… Read More
NACSYS Launch
Atlantic Pharma is pleased to announce the launch of NACSYS Acetylcysteine 600mg effervescent tablets. A new option in the treatment of… Read More
Medicines Optimisation Meeting
Atlantic Pharma were present at a recent conference for NHS Medicines Optimisation Managers in Birmingham. With a stated company aim of… Read More
